NicholasScanlonMD(He/Him)

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions, Clinical & Laboratory Immunology

Assistant Clinical Professor

Dr. Scanlon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8899 University Center Ln
Suite 230
San Diego, CA 92122
Fax+1 404-616-9204

Assistant Professor of Allergy and Immunology at UC San Diego.

Interests in primary and secondary immunodeficiency.

University of California (San Diego) Medical CenterFellowship, Allergy and Immunology, 2021 - 2023
Emory University School of MedicineChief Residency, Internal Medicine, 2020 - 2021
Emory University School of MedicineResidency, Internal Medicine, 2017 - 2020
University of Alabama School of MedicineClass of 2017
Harding UniversityBS, Biochemistry & Molecular Biology, Summa Cum Laude, 2008 - 2012

Chrysalis Project Award American Academy of Allergy, Asthma, and Immunology, 2019
NIH StARR Grant Emory University School of Medicine, 2019
SPARK Award American College of Allergy, Asthma, and Immunology, 2018
HHMI Medical Research Fellow Howard Hughes Medical Insitute, 2015
Join now to see all

Adaptive COVID-19 Treatment Trial (ACTT) Start of enrollment: 2020 Feb 21
Completed
Phase 3
Adaptive COVID-19 Treatment Trial 2 (ACTT-2) Start of enrollment: 2020 May 08
Completed
Phase 3
Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Start of enrollment: 2020 Aug 05
Completed
Phase 3
Adaptive COVID-19 Treatment Trial 4 (ACTT-4) Start of enrollment: 2020 Dec 02
Completed
Phase 3
Join now to see all

PubMed

1 citations
Refractory Status Epilepticus Associated With a Pathogenic Variant in TNFRSF13B.
Jennifer H Yang, Nicholas Scanlon, Wonhee Woo, Jamie N LaBuzetta, Cynthia Gonzalez
Cureus. 2023-11-01
2 citations
Anaphylaxis From Ethylene Oxide-Sterilized Dialysis Tubing and Needles: A Case Report.
Clarkson Crane, Robyn A Cunard, Natalie Sweiss, Nicholas Scanlon, Taylor A Doherty
American Journal of Kidney Diseases. 2023-08-01
30 citations
Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.
Varun K Phadke, Nicholas Scanlon, Stanley C. Jordan, Nadine Rouphael
Current Transplantation Reports. 2021-03-04

Journal Articles

The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients
Scanlon, N, Saklawi, Y, Rouphael, N., Frontiers in Immunology, 11/25/2020
Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy
Kuruvilla, M, Shih, J, Patel, K, and Scanlon, N., Allergy and Asthma Proceedings, 1/1/2019
Brief Report: Enhanced Allogeneic Cellular Responses to Mismatched HLA-B Antigens Results in More Efficient Killing of HIV Infected Cells
Sabbaj, S, Scanlon, N, Du, VY, Wang, Y, Tang, J, Hunter, E, and Goepfert, PA, JAIDS, 4/15/2016

Low- or No-Risk Penicillin Allergy Can Be Confirmed with Oral Challenge TestFebruary 25th, 2019

Medical Student Representative, Advisory Committee on LGBTQ Issues - American Medical Association 2015 - Present
Chair, Minority Issues Committee - American Medical Association Medical Student Section 2013 - 2015

ACAAI 2018: Oral Amoxicillin Challenge Safe in Low-Risk Patients With Penicillin Allergy Labelhttps://www.practiceupdate.com/content/acaai-2018-oral-amoxicillin-challenge-safe-in-low-risk-patients-with-penicillin-allergy-label/76265